Phase II Trial of Tesamorelin for Cognition in Aging HIV-Infected Persons
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Fred Sattler, MD
University of Southern California
Principal Investigator - Ronald J Ellis, MD, PhD
University of California, San Diego
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Keck School of Medicine of the University of Southern California
Los Angeles, California, United States
- Palmtree
Palm Springs, California, United States
- Hiv Neurobehavioral Research Program (hnrp)
San Diego, California, United States
- University of California, San Francisco
San Francisco, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Feb 2017
- Primary completion
- 15 Oct 2023
- Completion
- 15 Oct 2023
- Last update posted
- 12 Mar 2026
- Registered enrollment
- 73
- Registry id
- NCT02572323
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.